EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Fate and state transitions during human blood vessel organoid development

Marina T Nikolova, Zhisong He, Makiko Seimiya, Gustav Jonsson, Wuji Cao, Ryo Okuda, Reiner A Wimmer, Ryoko Okamoto, Josef M Penninger, J Gray Camp, Barbara Treutlein

Cell · 2025-06 · 188 (12) · 3329-3348.e31

DOI: 10.1016/j.cell.2025.03.037 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Cell, 2025-06. Verfasst von Marina T Nikolova und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biosystems Science and Engineering, ETH Zurich, Basel, Switzerland. Hauptthemen laut MEDLINE: Organoids, Blood Vessels. Die Arbeit wurde bisher 54-mal zitiert (Crossref) und nennt 140 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Innovative Medicines Initiative, Bavarian State Ministry of Education Science and Art, Swiss National Science Foundation.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Human blood vessel organoids (hBVOs) have emerged as a system to model human vascular development and disease. Here, we use single-cell multi-omics together with genetic and signaling pathway perturbations to reconstruct hBVO development. Mesodermal progenitors bifurcate into endothelial and mural fates in vitro, and xenografted BVOs acquire definitive arteriovenous endothelial cell specification. We infer a gene regulatory network and use single-cell genetic perturbations to identify transcription factors (TFs) and receptors involved in cell fate specification, including a role for MECOM in endothelial and mural specification. We assess the potential of BVOs to generate organotypic states, identify TFs lacking expression in hBVOs, and find that induced LEF1 overexpression increases brain vasculature specificity. Finally, we map vascular disease-associated genes to hBVO cell states and analyze an hBVO model of diabetes. Altogether, we provide a comprehensive cell state atlas of hBVO development and illuminate the power and limitation of hBVOs for translational research.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

OrganoidsBlood VesselsHumansAnimalsEndothelial CellsMiceGene Regulatory NetworksTranscription FactorsCell DifferentiationLymphoid Enhancer-Binding Factor 1

Stichwörter der Autor:innen

arteriovenous specificationhuman blood vessel organoidhuman developmentorganoid cell atlassingle-cell genomicssingle-cell perturbation screen

Substanzen

Transcription FactorsLEF1 protein, humanLymphoid Enhancer-Binding Factor 1

Autor:innen und Institutionen

  • Department of Biosystems Science and Engineering, ETH Zurich, Basel, Switzerland.
  • Institute of Molecular Biotechnology of the Austrian Academy of Sciences, Vienna, Austria; Vienna BioCenter PhD Program, Doctoral School of the University of Vienna and Medical University of Vienna, 1030 Vienna, Austria.
  • Institute of Human Biology, Roche Pharma Research and Early Development, Roche Innovation Center Basel, Basel, Switzerland.
  • Institute of Molecular Biotechnology of the Austrian Academy of Sciences, Vienna, Austria; Roche Pharma Research and Early Development, Roche Innovation Center, Basel, Switzerland.
  • Institute of Molecular Biotechnology of the Austrian Academy of Sciences, Vienna, Austria; Department of Medical Genetics, Life Science Institute, University of British Columbia, Vancouver, BC V6T 1Z3, Canada; Departmen…
  • Institute of Human Biology, Roche Pharma Research and Early Development, Roche Innovation Center Basel, Basel, Switzerland; Biozentrum, University of Basel, Basel, Switzerland. Electronic address: jarrettgrayson.camp@un…

Förderung

  • Innovative Medicines Initiative
  • Bavarian State Ministry of Education Science and Art
  • Swiss National Science Foundation
  • Silicon Valley Community Foundation
  • Canadian Institutes of Health Research
  • Canada Research Chairs Program
  • European Research Council

Zitieren

APA

Nikolova, M. T., He, Z., Seimiya, M., Jonsson, G., Cao, W., Okuda, R., Wimmer, R. A., Okamoto, R., Penninger, J. M., Camp, J. G., & Treutlein, B. (2025). Fate and state transitions during human blood vessel organoid development. Cell, 188(12), 3329-3348.e31. https://doi.org/10.1016/j.cell.2025.03.037

Vancouver

Nikolova MT, He Z, Seimiya M, Jonsson G, Cao W, Okuda R, et al. Fate and state transitions during human blood vessel organoid development. Cell. 2025;188(12):3329-3348.e31. doi:10.1016/j.cell.2025.03.037

BibTeX
@article{Nikolova2025,
  author = {Nikolova, Marina T and He, Zhisong and Seimiya, Makiko and Jonsson, Gustav and Cao, Wuji and Okuda, Ryo and Wimmer, Reiner A and Okamoto, Ryoko and Penninger, Josef M and Camp, J Gray and Treutlein, Barbara},
  title = {Fate and state transitions during human blood vessel organoid development},
  journal = {Cell},
  year = {2025},
  volume = {188},
  number = {12},
  pages = {3329--3348.e31},
  doi = {10.1016/j.cell.2025.03.037}
}
Kostenlos starten →